Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Ricerca

PDF

Prevalenza dell’ADHD in una popolazione pediatrica e sua esposizione al trattamento psico–comportamentale e farmacologico

Prevalence of ADHD in the Italian paediatric population and rate of exposition to pharmacological and behavioural treatment

Dino Maschietto1, Elisabetta Baioni1, Claudio Vio1, Federica Novello1, Elena A.P. Germinario2, Federica M. Regini2, Pietro Panei2
1U.O.C. Neuropsichiatria Infantile AULSS 10 “Veneto Orientale” San Donà di Piave, Veneto
2Dip.to del Farmaco, Istituto Superiore di Sanità, Roma

Dicembre 2012

Contenuto HTML non disponibile.
Classificazione MeSH
Central Nervous System Stimulants (15) Combined Modality Therapy (5) Epidemiologic Studies (28) Prevalence (58)
Leggi anche
EL Striscia... la notizia
Celiachia in forte aumento, in 20 anni raddoppiati casi - OMS: grandi progressi nella riduzione dell...
M.V. Abate (a cura di) · 2019 · 3 temi in comune
EL Il punto su
Efficacia e sicurezza di paracetamolo nei primi 1.000 giorni di vita: opinione di esperti
Scaglione F, Lora Aprile P, Peccarisi L, Villaccio · 2025 · 3 temi in comune
RI Casi indimenticabili
Storie di pazienti con ADHD
Skabar A. · 2025 · 3 temi in comune
RI Se la conosci la riconosci
La sindrome di Malan
Ramazzotti S, Nuvoli V, Baldo F. · 2026 · 2 temi in comune

Bibliografia

Bibliografia
 
  1. Dopheide JA, Plizka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 2009;29:656-79.
  2. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998;279:1100-07.
  3. Gallucci F, Bird HR, Berardi C, Gallai V, Pfanner P, Weinberg A. Symptoms of attention-deficit hyperactivity disorder in an Italian school sample: findings of a pilot study. J Am Acad Child Adolesc Psychiatry 1993;32:1051-58.
  4. Besoli G, Venier D. Il disturbo di attenzione con iperattività: indagine conoscitiva tra i pediatri di famiglia in Friuli-Venezia Giulia. Quaderni acp 2003;X:8-9.
  5. Corbo S, Marolla F, Sarno V, Torrioli MG, Vernacotola S. Prevalenza dell’ADHD in bambini seguiti dal Pediatra di Famiglia. Medico e Bambino 2003;1:22-5.
  6. Ciotti F. La sindrome ipercinetica “pura” fra gli alunni nel territorio cesenate. Quaderni acp 2003, X:18-20.
  7. Sarno V. Il pediatra alle prese con i problemi psicorelazionali: uno studio pilota. Medico e Bambino 2003;1:S9-S12.
  8. Camerini GB, Coccia M, Caffo E. Il Disturbo da Deficit dell’Attenzione-Iperattività: analisi della frequenza in una popolazione scolastica attraverso questionari agli insegnanti. Psichiatria dell’infanzia e dell’adolescenza 1996:63:587-94.
  9. Culpepper L. Primary care treatment of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006; 67(Suppl 8):51-58.
  10. MTA Cooperative Group. A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56:1073-96.
  11. Molina BS, Hinshaw SP, Swanson JM, et al. The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study. J Am Acad Child Adolesc Psychiatry 2009; 48:484-500.
  12. Greene RW, Biederman J, Faraone SV, Ouellette CA, Penn C, Griffin SM. Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1996; 35:571-78.
  13. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29:546-57.
  14. Biederman J, Mick E, Faraone SV. Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder. J Pediatr 1998;133:544-51.
  15. Jensen PS. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting. Am J Manag Care 2009;15(5 Suppl):S129-140.
  16. Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 2001; 165:1475-88.
  17. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 2003; 60:204-211.
  18. Favreau A, Deseille-Turlotte G, Brault F, et al. Benefit of the extended-release methylphenidate formulations: a comparative study in childhood. Arch Pediatr 2006; 13:442-448.
  19. Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics 2008; 121:e314-320.
  20. Bakken RJ, Paczkowski M, Kramer HP, et al. Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study. Curr Med Res Opin 2008; 24:449-460.
  21. Prasad S, Steer C. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder: clinical approaches and review of current available evidence. Paediatr Drugs 2008;10:39-47.
  22. Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 2009; 23(Suppl 1):21-31.
  23. Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. Italian Attention-Deficit/Hyperactivity Disorder Registry. Pediatrics 2004;114:514.
  24. Bonati M, Panei. Il registro dell’ADHD: lo stato dell’arte. Medico e Bambino 2009;5:279-81.
  25. Knellwolf AL, Deligne J, Chiarotti F, et al. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 2008; 64:311-7.